SM
Samie Mohammed Aldoori
About Samie Mohammed Aldoori
Data last updated:
Samie Mohammed Aldoori is a Director at S. Zhaveri Pharmakem Private Limited (since 2024) and Director at Crescent R&D Private Limited (since 2023). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹49.47 Cr; the largest is S. Zhaveri Pharmakem Private Limited at ₹34.80 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 S. Zhaveri Pharmakem Private Limited U51397MH2005PTC153790 | Director | 30 May 2024 | 2005 | ₹34.80 Cr (FY 2025) | Active |
 Crescent R&D Private Limited U74900TN2014PTC096380 | Director | 10 May 2023 | 2014 | ₹14.67 Cr (FY 2024) | Active |
Board colleagues of Samie Mohammed Aldoori
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anish Rajesh Parmar | 10727022 | S. Zhaveri Pharmakem Private Limited | Director |
| Laith Khalid Aldoori | 10098000 | S. Zhaveri Pharmakem Private Limited , Crescent R&D Private Limited | Director |
| Mohammed Khalid Al-Doori | 10097999 | S. Zhaveri Pharmakem Private Limited , Crescent R&D Private Limited | Director |
| Ravin Pawar | 10748739 | Crescent R&D Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Samie Mohammed Aldoori
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Samie Mohammed Aldoori
Samie Mohammed Aldoori currently holds 2 directorships: S. Zhaveri Pharmakem Private Limited (Director, since 30 May 2024, revenue ₹34.80 Cr (FY 2025)); Crescent R&D Private Limited (Director, since 10 May 2023, revenue ₹14.67 Cr (FY 2024)).
Samie Mohammed Aldoori was first appointed on 10 May 2023 as Director at Crescent R&D Private Limited. The most recent appointment on record is 30 May 2024 at S. Zhaveri Pharmakem Private Limited.
The 2 current companies of Samie Mohammed Aldoori that report revenue have a combined latest revenue of ₹49.47 Cr: S. Zhaveri Pharmakem Private Limited ₹34.80 Cr (FY 2025); Crescent R&D Private Limited ₹14.67 Cr (FY 2024).
The current boards of Samie Mohammed Aldoori's companies include Anish Rajesh Parmar (S. Zhaveri Pharmakem Private Limited), Laith Khalid Aldoori (S. Zhaveri Pharmakem Private Limited), Mohammed Khalid Al-Doori (S. Zhaveri Pharmakem Private Limited), Ravin Pawar (Crescent R&D Private Limited).